# Voyager Therapeutics, Inc. (VYGR)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/VYGR/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 2.59M | $ -27.94M | $ -33.43M | $ 34.57M | $ 173.67M |
| 2025 | $ 41.34M | $ -122.58M | $ -138.29M | $ 36.50M | $ 196.08M |
| 2024 | $ 84.09M | $ -68.32M | $ -19.79M | $ 43.73M | $ 299.76M |
| 2023 | $ 270.32M | $ 143.08M | $ 80.73M | $ 20.29M | $ 236.32M |
| 2022 | $ 45.70M | $ -51.84M | $ -16.76M | $ 23.13M | $ 59.02M |
| 2021 | $ 44.47M | $ -84.63M | $ -65.54M | $ 44.18M | $ 95.06M |
| 2020 | $ 218.01M | $ 46.81M | $ -138.62M | $ 47.61M | $ 154.32M |
| 2019 | $ 134.74M | $ -56.27M | $ 52.85M | $ 34.17M | $ 99.51M |
| 2018 | $ 10.06M | $ -116.60M | $ -26.67M | $ 0 | $ 46.45M |
| 2017 | $ 13.65M | $ -95.16M | $ -88.02M | $ 0 | $ 134.05M |
| 2016 | $ 19.56M | $ -55.30M | $ -65.37M | $ 0 | $ 135.92M |
| 2015 | $ 24.34M | $ -41.66M | $ 56.54M | $ 0 | $ 169.07M |
| 2014 | $ 0 | $ -23.70M | $ -21.06M | $ 6.31M | $ 1.15M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.20 |
| Liabilities / Eq | 0.26 |
| Current Ratio | 8.42 |

## Other views

- [Metrics](https://sponda.capital/en/VYGR.md)
- [Charts](https://sponda.capital/en/VYGR/charts.md)
- [Compare](https://sponda.capital/en/VYGR/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.